Sunaga Y, Nishikawa M, Inaba K, Hirozane N, Inoue N, Shikata N, Inada M
Second Department of Internal Medicine, Kansai Medical University.
Nihon Naibunpi Gakkai Zasshi. 1989 May 20;65(5):525-36. doi: 10.1507/endocrine1927.65.5_525.
Described herein are two brothers with 21-hydroxylase deficiency (21-OHD) associated with adrenal tumors, and these possible mechanisms are discussed. A 34-year-old male was admitted on Jan. 9, 1984 because of an enlarged and tender left breast. Physical examination revealed short stature (152 cm, 76.5 kg), gynecomastia and shortening of metacarpal bone. His testes were small (2.6 X 1.6 X 1.9 cm). Urinary excretion of 17-OHCS was within normal range (5.9 mg/day), but those of 17-KS, 17-KGS and pregnanetriol were markedly increased (44.4, 110 and 22.6 mg/day, respectively). Plasma concentrations of progesterone and ACTH and urinary excretions of estrone, estradiol and estriol were also increased. Urinary excretions of 17-KS were decreased to 11.7 mg/day and 17-KGS to 22.3 mg/day after the ingestion of 2 mg/day dexamethasone for two days. The computed tomography and a scintigraphy with 131I-Adosterol revealed a tumor in the left adrenal gland, and the adrenal arteriography revealed a neovascularity and a tumor stain in the tumor. These data indicated that the patient was suffering from both 21-OHD and the left adrenal tumor. At this point, adenoma or adenocarcinoma of the adrenal gland was suspected. The left adrenal tumor (85 g) was resected on April 10, 1984, and the pathological diagnosis was adrenal adenoma. The patient's endocrinological abnormalities, however, did not improve after the operation. Urinary excretions of 17-KS and KGS were increased to 57.9 and 108.5 mg/day, respectively, in the patient's elder brother, and 63.3 and 127.9 mg/day, respectively, in his younger brother, indicating that they also had 21-OHD. Interestingly, an adrenal tumor was diagnosed by abdominal computed tomography in the elder brother who had the same HLA typing as the present case. The three brothers had 21-OHD, and two of them had both 21-OHD and adrenal tumor. To our knowledge, this is the first report documenting the co-existence of adrenal tumors in brothers with 21-OHD. This suggests that adenoma can be one of the complications of 21-OHD, probably due to the chronic stimulation by ACTH, and that a possible linkage to HLA may exist in such cases.
本文描述了两兄弟患有与肾上腺肿瘤相关的21-羟化酶缺乏症(21-OHD),并对其可能的机制进行了讨论。一名34岁男性于1984年1月9日因左侧乳房肿大且压痛入院。体格检查发现身材矮小(身高152cm,体重76.5kg)、男性乳房发育和掌骨缩短。其睾丸较小(2.6×1.6×1.9cm)。尿17-羟皮质类固醇(17-OHCS)排泄量在正常范围内(5.9mg/天),但尿17-酮类固醇(17-KS)、17-酮皮质类固醇(17-KGS)和孕三醇排泄量显著增加(分别为44.4、110和22.6mg/天)。血浆孕酮和促肾上腺皮质激素(ACTH)浓度以及尿雌酮、雌二醇和雌三醇排泄量也增加。连续两天每日服用2mg地塞米松后,尿17-KS排泄量降至11.7mg/天,17-KGS降至22.3mg/天。计算机断层扫描和131I-阿多甾醇闪烁扫描显示左肾上腺有肿瘤,肾上腺动脉造影显示肿瘤内有新生血管和肿瘤染色。这些数据表明该患者患有21-OHD和左肾上腺肿瘤。此时,怀疑为肾上腺腺瘤或腺癌。1984年4月10日切除了左肾上腺肿瘤(85g),病理诊断为肾上腺腺瘤。然而,患者术后内分泌异常并未改善。患者哥哥的尿17-KS和17-KGS排泄量分别增至57.9和108.5mg/天,弟弟的分别增至63.3和127.9mg/天,表明他们也患有21-OHD。有趣的是,与本病例具有相同人类白细胞抗原(HLA)分型的哥哥经腹部计算机断层扫描诊断出患有肾上腺肿瘤。这三兄弟患有21-OHD,其中两人同时患有21-OHD和肾上腺肿瘤。据我们所知,这是首篇记录患有21-OHD的兄弟同时存在肾上腺肿瘤的报告。这表明腺瘤可能是21-OHD的并发症之一,可能是由于ACTH的慢性刺激所致,并且在这种情况下可能与HLA存在某种联系。